Pharma services company Clinigen Group PLC (LON:CLIN) has appointed Nick Keher as its new chief financial officer.
Keher, who is set to take up his new role on 19 March, joins from Canadian investment bank Royal Bank of Canada, where he was a managing director and head of the European healthcare equity research team.
He is replacing the outgoing Martin Abell who has resigned and is due to leave a couple of weeks after Keher’s arrival.
“Nick brings considerable pharmacy and pharmaceutical experience as well as financial expertise, both as an accountant and from working in the financial markets,” said chief executive Shaun Chilton.
“He has a deep knowledge and insight of our business through his research and analysis of Clinigen since its IPO in 2012. He will be a key addition to the executive management team.”
Clinigen shares were down 2.1% to 794p in late morning trading on Tuesday.